Axon Enterprise Inc. (AXON): Price and Financial Metrics
AXON Price/Volume Stats
| Current price | $631.69 | 52-week high | $698.67 |
| Prev. close | $615.68 | 52-week low | $241.72 |
| Day low | $605.09 | Volume | 7,032,700 |
| Day high | $633.21 | Avg. volume | 614,738 |
| 50-day MA | $555.47 | Dividend yield | N/A |
| 200-day MA | $383.37 | Market Cap | 48.17B |
AXON Stock Price Chart Interactive Chart >
Axon Enterprise Inc. (AXON) Company Bio
Axovant Sciences is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of dementia, a condition characterized by significant decline in mental capacity and impaired daily function. The company was founded in 2014 and is based in Hamilton, Bermuda.
AXON Price Returns
| 1-mo | 0.07% |
| 3-mo | 60.62% |
| 6-mo | 115.81% |
| 1-year | 143.87% |
| 3-year | 297.26% |
| 5-year | N/A |
| YTD | 144.53% |
| 2023 | 55.69% |
| 2022 | 5.69% |
| 2021 | 28.13% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...